Literature DB >> 7535747

C to T and/or G to A transitions are responsible for loss of a MspI restriction site at the 5'-end of the human apolipoprotein AI gene.

X L Wang1, R Badenhop, K E Humphrey, D E Wilcken.   

Abstract

We detected the loss of a MspI restriction site by a C to T transition at +83 bp and a G to A transition at +84 bp of the 5'-end non-coding region of the human apolipoprotein AI gene. This base change occurred at the "hot spot" (CCGG) for methylation, which may be important in the regulation of gene expression. The population frequency for the loss of the MspI site is 6.1%.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7535747     DOI： 10.1007/bf00208984

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


  4 in total

1.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

2.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Authors:  M J Stampfer; F M Sacks; S Salvini; W C Willett; C H Hennekens
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

3.  Gene structure of human apolipoprotein A1.

Authors:  C C Shoulders; A R Kornblihtt; B S Munro; F E Baralle
Journal:  Nucleic Acids Res       Date:  1983-05-11       Impact factor: 16.971

4.  Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations.

Authors:  H Paul-Hayase; M Rosseneu; D Robinson; J P Van Bervliet; J P Deslypere; S E Humphries
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132
  4 in total
  5 in total

1.  Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.

Authors:  X L Wang; S X Liu; R M McCredie; D E Wilcken
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

2.  Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.

Authors:  F Cardona; F J Tinahones; E Collantes; A Escudero; E García-Fuentes; F J Soriguer
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

3.  Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity.

Authors:  Elizabeth Suchi Chen; Diego Robles Mazzotti; Tatiane Katsue Furuya; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Lara Quirino Araujo; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 3.984

4.  Association of the Apolipoprotein A-I Gene Polymorphisms with Cardiovascular Disease Risk Factors and Atherogenic Indices in Patients from Assam, Northeast India.

Authors:  K Bora; M S Pathak; P Borah; Md I Hussain; D Das
Journal:  Balkan J Med Genet       Date:  2017-06-30       Impact factor: 0.519

5.  Single nucleotide polymorphisms of APOA1 gene and their relationship with serum apolipoprotein A-I concentrations in the native population of Assam.

Authors:  Kaustubh Bora; Mauchumi Saikia Pathak; Probodh Borah; Md Iftikar Hussain; Dulmoni Das
Journal:  Meta Gene       Date:  2015-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.